[ad_1]
AYUSH Ministry and the Scientific and Industrial Research Council (CSIR) are working together to validate four Ayush formulations against Covid-19, Union Minister Shripad Y Naik said on Twitter on Thursday. He also said testing will begin in a week.
“@Moayush and @CSIR_IND are working together to validate four Ayush formulations against # COVID19Pandemic and testing will begin within a week. These formulations will be tested as complementary therapy and standard care for COVID-19 patients. I am confident and quite optimistic that our traditional medicinal system will show the way to overcome this pandemic, ”Naik said on Twitter.
I am confident and quite hopeful that our traditional medicinal system will show the way to overcome this pandemic.
– Shripad Y. Naik (@shripadynaik) May 14, 2020
CSIR Director-General Shekhar Mande and Ayurveda and AYUSH Secretary Vaidya Rajesh Kotecha had said on Wednesday that the result would come in three months.
“Last week, the Union Health Minister Harsh Vardhan announced that CSIR and AYUSH will work together on four different formulations,” said Mande.
Kotecha said that the AYUSH and CSIR collaboration has a broader perspective. “This is a once in a lifetime opportunity. This type of study never happened in our country. These four candidates are: Ashwagandha, Yashtimadhu (Mulethi), Guduchi + Pippali (Giloy) and AYUSH-64, which was invented for the treatment of malaria and its reuse continues, “he said.
“So we are doing two types of stimulus studies as profile access in the high-risk population for Ashwagandha. We have also planned a competitive study between hydroxychloroquine and Ashwagandha, “he added.
The AYUSH secretary said these four formulations will be tested as supplemental therapy and standard care for Covid-19 patients.
“It is a multicenter clinical study in different parts of the country and of variable design. For example, this clinical study is for the protocol. We have formed the working group and have prepared a guide for the clinical trial. Some of the best scientists in the country in the field of medicine, from CSIR and others, also reviewed this, “said Kotecha.
“We have taken the ICMR’s advice to make it so robust that it can be published in a very high impact magazine,” he added.
Mande said Ayurveda is based on thousands of years of clinical practice that has been followed.
“So we trust Ayurveda. We cannot show the mechanism of action as modern medicine does. Ayurvedic practices have existed long before modern medical practices. Therefore, it is important that we validate some of the Ayurvedic principles. So, it is the perfect time in the fight against the coronavirus. We tested some of the ayurvedic formulations against the coronavirus, ”he said.
I had previously cited the example of China. “The Chinese have done very well in the practices of traditional Chinese medicine. They have been able to demonstrate why some of their medications are effective, ”said Mande.
.
[ad_2]
